How does aprocitentan lower blood pressure?
Aprocitentan blocks endothelin receptors in blood vessel walls, stopping a natural chemical that tightens vessels and raises pressure. In the PRECISION trial, this dual blockade lowered resistant high blood pressure by 10–15 mmHg [1].
Your body makes a chemical called endothelin-1 (ET-1) that tells blood vessels to squeeze tight. In resistant high blood pressure, too much ET-1 causes vessels to stay constricted, raising pressure even on three or more drugs. Aprocitentan blocks both ET-A and ET-B receptors, stopping that squeeze [1].
Think of it like turning down the volume on a speaker. ET-1 is the amplifier; aprocitentan is the volume knob. When you block both receptor types, vessels relax, blood flows easier, and pressure drops. This also reduces inflammation and fibrosis (scarring) in vessel walls, which helps long-term [1].
The PRECISION trial showed a 10–15 mmHg drop in systolic pressure (the top number) when aprocitentan was added to existing BP drugs [1]. For resistant hypertension—pressure that won't budge on three or more medications—this is a meaningful win. Most patients see the full effect within 8 weeks [9].
Ask your doctor: 'How many weeks should I wait before we check if aprocitentan is working?' Most clinicians recheck blood pressure at 4 weeks, then again at 8 weeks to confirm the drop [1].